Purchase Order 75D30121P10630

The Defense Logistics Agency Troop Support Medical awarded a $411,870 delivery order to Fisher Scientific Company L.L.C. for quality control testing of human papillomavirus (HPV) negative kits containing five samples per package. The order was placed against an unspecified government-wide acquisition contract vehicle held by Fisher Scientific's parent company, Thermo Electron Corporation Financial Services Division. Performance will occur at Fisher Scientific's Pittsburgh, Pennsylvania...

This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $181,143.20, is for the delivery of HPV (Human Papillomavirus) detection kits. The contract was awarded by the U.S. Army Medical Command (MEDCOM), a Defense agency, and has a completion date of September 30, 2019. The contract is a Firm Fixed Price Purchase Order and does not...

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh has awarded a $85,500 firm fixed price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, small disadvantaged business, for the delivery of an HPV Detection RUO Assay. This purchase order will provide the CDC Pittsburgh location with HPV test kits, reagents, and Novaplex II HPV28 detection kits to support the agency's public health mission related to HPV screening and prevention....

Roche Diagnostics Corporation was awarded a $409,522.65 firm fixed price blanket purchase agreement call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 to deliver HPV test kits. The contract was issued against GSA Schedule 66-III for Critical Analyzers, Laboratory and has a period of performance through September 30, 2021. Place of performance will be in Castleton, Indiana. No set-aside designation was used for this contract...

This is a firm-fixed price purchase order awarded to Roche Diagnostics Corporation by the U.S. Army Medical Command (MEDCOM) for the provision of 960 HPV (Human Papillomavirus) detection kits. The contract has a ceiling value of $388,211.32 and a performance period ending on September 30, 2022. The contract was awarded on October 1, 2019 and does not have a set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...

This is a BPA call contract awarded by the Veterans Integrated Service Network 12 (VISN12) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract is for the provision of reagents and consumables for human papillomavirus (HPV), chlamydia (CT), and gonorrhea (NG) testing, with a ceiling value of $175,128.60 and a performance period ending on September 30, 2021. The contract was...

This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Agilent Technologies Inc., a manufacturer of scientific instruments and equipment. The contract is for customized reagent kits required for human papillomavirus (HPV) whole genome sequencing using Agilent's SureSelect target enrichment technology and bioinformatics support. The contract has a ceiling value of $89,678.52 and an ultimate completion date of October 27, 2018. The order was...

Roche Diagnostics Corporation was awarded a $387,011.95 firm fixed price blanket purchase agreement call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 to provide human papillomavirus (HPV) testing kits. The contract was awarded on October 1, 2019 under the Critical Analyzers, Laboratory GSA Schedule with performance required at a location in Castleton, Indiana by November 16, 2020. No set-aside designation was applied to...

This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostic products. The contract, valued at $497,149.96, is for the delivery of human papillomavirus (HPV) detection kits. The contract is not set aside for any type of small business. Roche Diagnostics has been awarded numerous federal contracts and task orders, including through General Services Administration (GSA) schedule...

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 12 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for $400,000.00 and has an ultimate completion date of March 31, 2026. It is for the provision of reagents and consumables for human papillomavirus (HPV), Chlamydia trachomatis (CT),...